Our latest release of our Industry Insights Newsletter is now available to download!

In this issue:

NEW SYSTEMS AND ICH GUIDELINES/ADDENDUM 

  • New EudraVigilance System
  • International Conference for Harmonisation (ICH) E9(R1) Addendum 
  • ICH E18 Guideline on Genomic Sampling and Management of Data
  • ICH E19 Guideline on Optimisation of Safety Data Collection 
  • Food and Drug Administration (FDA) Revises ICH Guideline M4E(R2) on Risk-Benefit Submissions 

BREXIT

  • EU Industry Associations Seek to Influence Brexit Negotiations 

EUROPE – GUIDELINES & REFLECTION/CONCEPT PAPERS 

  • Revised Guideline on First-In-Human (FIH) Clinical Trials 
  • New Guidelines for Advanced Therapies 
  • Draft Reflection Paper on Designing Medicines for the Elderly, Comments by 31 January 2018 
  • Draft Reflection Paper on Data Extrapolation in Paediatric Medicine Development, Comments by 14 January 2018 
  • Draft Concept Paper on Genetic Polymorphism in Drug Metabolism (Comments Deadline now Closed) 

REGULATORY INSPECTIONS 

  • FDA, EMA and MHRA (Medicines and Healthcare products Regulatory Agency)

USA

  • New at the FDA 

AND MUCH MORE!

Follow this link to our latest edition and we welcome your feedback.